Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

GINKGO BIOWORKS HOLDINGS, INC.

(DNA)
  Report
Delayed Nyse  -  04:00 2022-09-30 pm EDT
3.120 USD   -0.32%
09/20Zymergen Investor Alert By The Former Attorney General Of Louisiana : Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Zymergen - ZY
PR
09/13The White House - Renee Wegrzyn Slated to Lead New Advanced Research Projects Agency for Health
AQ
09/12Biden executive order to fund U.S. biomanufacturing industry
RE
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/26/2022 09/27/2022 09/28/2022 09/29/2022 09/30/2022 Date
2.8(c) 2.89(c) 3.47(c) 3.13(c) 3.12(c) Last
19 118 810 21 125 951 43 725 950 24 891 417 28 229 527 Volume
0.00% +3.21% +20.07% -9.80% -0.32% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 430 M - -
Net income 2022 -1 886 M - -
Net cash position 2022 1 454 M - -
P/E ratio 2022 -2,77x
Yield 2022 -
Sales 2023 401 M - -
Net income 2023 -535 M - -
Net cash position 2023 1 222 M - -
P/E ratio 2023 -11,2x
Yield 2023 -
Capitalization 5 401 M 5 401 M -
EV / Sales 2022 9,18x
EV / Sales 2023 10,4x
Nbr of Employees 641
Free-Float 53,3%
More Financials
Company
Ginkgo Bioworks Holdings, Inc. is engaged in building the horizontal platform for cell programming. The Company's platform is used to program cells on behalf of its customers. Its cell programs are designed to enable biological production of products such as therapeutics, key food ingredients, and chemicals derived from petroleum. The Company operates through two segments: Foundry and Biosecurity. Foundry consists... 
More about the company
Ratings of Ginkgo Bioworks Holdings, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about GINKGO BIOWORKS HOLDINGS, INC.
09/20Zymergen Investor Alert By The Forme : Kahn Swick & Foti, LLC Investigates Adequacy of Pri..
PR
09/13The White House - Renee Wegrzyn Slated to Lead New Advanced Research Projects Agency fo..
AQ
09/12Biden executive order to fund U.S. biomanufacturing industry
RE
09/01Ginkgo Bioworks Appoints Dr. Behzad Mahdavi as Senior Vice President of Biopharma Manuf..
PR
09/01Ginkgo Bioworks Appoints Behzad Mahdavi as Senior Vice President of Biopharma Manufactu..
CI
08/24Ayana Bio Announces Appointment of Frank Jaksch as Chief Executive Officer
PR
08/19Sector Update: Health Care Stocks Cross Friday Finish Line Slightly Higher
MT
08/19Sector Update: Health Care
MT
08/19Ginkgo Bioworks Acquires Epidemiological Data Infrastructure Assets From Baktus
MT
08/19Ginkgo Bioworks Announces Strategic Purchase of Epidemiological Data Infrastructure Ass..
PR
08/19Ginkgo Bioworks Holdings, Inc. agreed to acquire Certain Epidemiological Data Infrastru..
CI
08/18Life Sciences and Medical Equipment Lead Healthcare to a Bullish August (WHSI, CEMI, IB..
AQ
08/16BTIG Adjusts Price Target on Ginkgo Bioworks Holdings to $6 From $5, Reiterates Buy Rat..
MT
08/16Raymond James Adjusts Price Target on Ginkgo Bioworks Holdings to $14.50 From $11.50, K..
MT
08/16Top Premarket Gainers
MT
More news
News in other languages on GINKGO BIOWORKS HOLDINGS, INC.
09/12Un décret de Biden pour financer l'industrie américaine de la biofabrication
09/01Ginkgo Bioworks nomme Behzad Mahdavi au poste de vice-président principal de la fabrica..
08/19Mise à jour sectorielle : Soins de santé
08/19Ginkgo Bioworks acquiert les actifs de l'infrastructure de données épidémiologiques de ..
08/15La perte nette de Ginkgo Bioworks se creuse alors que les ventes augmentent au deuxième..
More news
Analyst Recommendations on GINKGO BIOWORKS HOLDINGS, INC.
More recommendations
ETFs positioned on GINKGO BIOWORKS HOLDINGS, INC.ETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Global X Guru Index ETF - USD1.42%-2.46%United_States
Defiance NextGen SPAC Derived ETF - USD1%-0.37%-NC
AAM Transformers ETF - USD0.21%-2.97%-NC
IShares Morningstar Small-Cap Growth ETF - USD0.16%-2.10%-NC
Vanguard Materials ETF - USD0.15%-2.91%United_States
More ETFs positioned on GINKGO BIOWORKS HOLDINGS, INC.
Chart GINKGO BIOWORKS HOLDINGS, INC.
Duration : Period :
Ginkgo Bioworks Holdings, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GINKGO BIOWORKS HOLDINGS, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 3,12 $
Average target price 7,98 $
Spread / Average Target 156%
EPS Revisions
Managers and Directors
Jason Kelly Co-Founder
Reshma Shetty Co-Founder
Mark Dmytruk Chief Financial Officer
Marijn E. Dekkers Independent Director
Bartholomew Canton Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
GINKGO BIOWORKS HOLDINGS, INC.-62.45%5 401
MODERNA, INC.-53.44%46 259
LONZA GROUP AG-36.15%36 760
IQVIA HOLDINGS INC.-35.80%33 784
SEAGEN INC.-11.49%25 236
ALNYLAM PHARMACEUTICALS, INC.18.03%24 025